- Home
- ELTX vs TTOO Comparison
ELTX vs TTOO Comparison
Compare ELTX & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- TTOO
- Stock Information
- Founded
- ELTX 2011
- TTOO 2006
- Country
- ELTX United States
- TTOO United States
- Employees
- ELTX N/A
- TTOO N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- TTOO Medical/Dental Instruments
- Sector
- ELTX Health Care
- TTOO Health Care
- Exchange
- ELTX Nasdaq
- TTOO Nasdaq
- Market Cap
- ELTX 49.7M
- TTOO 36.4M
- IPO Year
- ELTX 2021
- TTOO 2014
- Fundamental
- Price
- ELTX $4.16
- TTOO $0.97
- Analyst Decision
- ELTX Buy
- TTOO Hold
- Analyst Count
- ELTX 2
- TTOO 1
- Target Price
- ELTX $10.00
- TTOO $5.00
- AVG Volume (30 Days)
- ELTX 16.1K
- TTOO 710.5K
- Earning Date
- ELTX 11-07-2024
- TTOO 11-13-2024
- Dividend Yield
- ELTX N/A
- TTOO N/A
- EPS Growth
- ELTX N/A
- TTOO N/A
- EPS
- ELTX N/A
- TTOO N/A
- Revenue
- ELTX N/A
- TTOO $7,164,000.00
- Revenue This Year
- ELTX N/A
- TTOO $50.31
- Revenue Next Year
- ELTX N/A
- TTOO $117.92
- P/E Ratio
- ELTX N/A
- TTOO N/A
- Revenue Growth
- ELTX N/A
- TTOO N/A
- 52 Week Low
- ELTX $2.96
- TTOO $0.90
- 52 Week High
- ELTX $11.45
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- ELTX 40.82
- TTOO 18.34
- Support Level
- ELTX $4.05
- TTOO $0.90
- Resistance Level
- ELTX $4.89
- TTOO $1.86
- Average True Range (ATR)
- ELTX 0.28
- TTOO 0.15
- MACD
- ELTX -0.06
- TTOO -0.00
- Stochastic Oscillator
- ELTX 27.37
- TTOO 5.72
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.